Sustained response to atogepant in episodic migraine: post hoc analyses of a 12-week randomized trial and a 52-week long-term safety trial.

Lipton RB, Nahas SJ, Pozo-Rosich P, Bilchik T, McAllister P, Finnegan M, Liu Y, Chalermpalanupap N, Dabruzzo B, Dodick DW

Open source

DOI: 10.1186/s10194-024-01783-6
Published: 2024 May 21
Container: The journal of headache and pain
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s10194-024-01783-6,
  title = {Sustained response to atogepant in episodic migraine: post hoc analyses of a 12-week randomized trial and a 52-week long-term safety trial.},
  author = {Lipton RB and Nahas SJ and Pozo-Rosich P and Bilchik T and McAllister P and Finnegan M and Liu Y and Chalermpalanupap N and Dabruzzo B and Dodick DW},
  year = {2024},
  journal = {The journal of headache and pain},
  doi = {10.1186/s10194-024-01783-6},
  url = {https://doi.org/10.1186/s10194-024-01783-6}
}

RIS

TY  - JOUR
TI  - Sustained response to atogepant in episodic migraine: post hoc analyses of a 12-week randomized trial and a 52-week long-term safety trial.
AU  - Lipton RB
AU  - Nahas SJ
AU  - Pozo-Rosich P
AU  - Bilchik T
AU  - McAllister P
AU  - Finnegan M
AU  - Liu Y
AU  - Chalermpalanupap N
AU  - Dabruzzo B
AU  - Dodick DW
PY  - 2024
JO  - The journal of headache and pain
DO  - 10.1186/s10194-024-01783-6
UR  - https://doi.org/10.1186/s10194-024-01783-6
ER  -

APA

RB, L., SJ, N., P, P., T, B., P, M., M, F., Y, L., N, C., B, D., & DW, D. (2024). Sustained response to atogepant in episodic migraine: post hoc analyses of a 12-week randomized trial and a 52-week long-term safety trial.. The journal of headache and pain. https://doi.org/10.1186/s10194-024-01783-6

Source records

pubmed · retrieved 2026-09-26T16:14:48.658Z